Ifosfamide, cisplatin, adriamycin combination chemotherapy in gynecologic cancer
Sawada, M.; Inagaki, M.; Hirota, Y.; Hongo, J.; Ozaki, M.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(11): 3091-3094
1987
ISSN/ISBN: 0385-0684 PMID: 3674894 Document Number: 292926
Thirteen patients with gynecologic cancer were treated with ifosfamide (2 g X 5), cisplatin (70 mg/m2) and adriamycin (20 mg/m2) combination chemotherapy. The response rate of 7 evaluable patients was 43%, with a median duration of survival of 14 months. Six patients with non-measurable disease are currently free from disease with a median duration of survival of 18 months. This combination caused reversible myelosuppression. No hemorrhagic cystitis was observed.
Document emailed within 1 workday
Related Documents
Takeuchi, S.; Fukui, I.; Higashi, Y.; Andoh, M.; Kihara, K.; Kitahara, S.; Horiuchi, S.; Oshima, H. 1989: Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 35(9): 1513-1517Chen, Y.M.; Perng, R.P.; Yang, K.Y.; Wu, H.W.; Lin, W.C.; Liu, J.M.; Tsai, C.M.; Whang-Peng, J. 2000: Combination chemotherapy with tamoxifen, ifosfamide, epirubicin and cisplatin in extensive-disease small-cell lung cancer Zhonghua Yi Xue Za Zhi 63(8): 605-611
Halim, A.; Wahba, H. 2012: Cisplatin-ifosfamide combination chemotherapy in metastatic triple-negative, anthracycline- and taxane-pretreated breast cancer patients; a phase II study Journal of BUON: Official Journal of the Balkan Union of Oncology 17(2): 254-258
Yasuda, T.; Kabuto, T.; Ishiguro, S.; Nakano, H.; Nakamori, S.; Ohigashi, H.; Hiratsuka, M.; Kameyama, M.; Sasaki, Y.; Ishikawa, O. 1995: Preoperative neoadjuvant chemotherapy with a combination of 5-fluorouracil, adriamycin and cisplatin (FAP) for advanced esophageal cancer invading trachea or main bronchus Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(11): 1538-1541
Kanamori, M.; Kumabe, T.; Saito, R.; Yamashita, Y.; Sonoda, Y.; Tominaga, T. 2010: The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases No Shinkei Geka. Neurological Surgery 38(11): 997-1005
Ohwada, S.; Miyamoto, Y.; Takeshita, M.; Fujii, T.; Uchida, O.; Tanahasi, Y.; Aoyagi, H.; Izuo, M. 1989: Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(10): 3487-3489
Lund, B.; Hansen, O.P.; Hansen, H.H.; Hansen, M. 1992: Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer Seminars in Oncology 19(1 Suppl 1: 26-29
Watanabe, A.; Taniguchi, M. 2005: A case of oropharyngeal cancer with multiple bone metastases from prostate cancer that responded to docetaxel, ifosfamide and cisplatin combination therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 65-67
Topuz, E.; Saip, P.; Aydmer, A.; Salihoğlu, Y.; Berkman, S.; Bengisu, E. 1998: Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer European Journal of Gynaecological Oncology 19(3): 265-270
Makhnova, E.V. 2003: Combination chemotherapy with Hemzar (gemcitabine) and cisplatin for relapsing and cisplatin-resistant ovarian cancer Voprosy Onkologii 49(1): 60-65
Zanetta, G.; Fei, F.; Mangioni, C. 2000: Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza Seminars in Oncology 27(1 Suppl 1: 23-27
Shirinian, M.; Lee, J.S.; Dhingra, H.H.; Greenberg, J.; Hong, W.K. 1992: Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report Seminars in Oncology 19(6 Suppl. 12): 58-63
Tokunaga, A.; Onda, M.; Mizutani, T.; Miyamoto, M.; Nomura, T.; Hayashi, H.; Kiyama, T.; Umehara, M.; Nishi, K.; Andoh, T. 1989: Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(12): 3713-3718
Kubota, Y.; Nakano, M.; Nagai, S.; Matsuoka, K.; Arakawa, H.; Horie, K.; Deguchi, T.; Kato, H. 2015: Dramatic response of penile cancer with inguinal lymph node metastases to neoadjuvant chemotherapy with paclitaxel, ifosfamide and cisplatin : a case report Hinyokika Kiyo. Acta Urologica Japonica 61(1): 33-37
Eagan, R.T.; Lee, R.E.; Frytak, S.; Scott, M.; Ingle, J.N.; Creagan, E.T.; Nichols, W.C. 1981: Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancer Cancer Clinical Trials 4(4): 381-388
Hoffman, P.C.; Masters, G.A.; Drinkard, L.C.; Krauss, S.A.; Samuels, B.L.; Golomb, H.M.; Vokes, E.E. 1996: Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies Seminars in Oncology 23(3 Suppl 6: 11-15
Ikeda, I.; Shuin, T.; Yao, M.; Kubota, Y.; Hosaka, M. 1993: New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases Hinyokika Kiyo. Acta Urologica Japonica 39(3): 237-242
Koizumi, W.; Tanabe, S.; Higuchi, K.; Sasaki, T.; Nakayama, N.; Nagaba, S.; Azuma, M.; Shimoda, T.; Nishimura, K.; Nakatani, K.; Saigenji, K. 2004: Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(12): 1957-1961
Ito, Y.; Ogawa, M.; Horikoshi, N.; Inoue, K.; Mukaiyama, T.; Imajou, K.; Ozeki, H.; Nagamine, D.; Shinagawa, K. 1987: Combination chemotherapy with cis-platinum, vinblastine and adriamycin for non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(12): 3295-3300
Einhorn, L.H.; Williams, S.D. 1978: Combination chemotherapy with cis-dichlorodiammineplatinum(II) and adriamycin for testicular cancer refractory to vinblastine plus bleomycin Cancer Treatment Reports 62(9): 1351-1353